Skip to main content

Find Clinical Trials

Home
Conditions
Stage III Pancreatic Cancer American Joint Committee on Cancer v8

Clinical trial condition

Stage III Pancreatic Cancer American Joint Committee on Cancer v8

Explore clinical trials studying Stage III Pancreatic Cancer American Joint Committee on Cancer v8. Study availability and eligibility vary by location and protocol.

2 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Stage III Pancreatic Cancer American Joint Committee on Cancer v8 trial results

Active, Not Recruiting

NeoOPTIMIZE: Early Switching of mFOLFIRINOX or Gemcitabine/Nab-Paclitaxel Before Surgery for the Treatment of Resectable, Borderline Resectable, or Locally-Advanced Unresectable Pancreatic Cancer

NCT04539808

Conditions: Pancreatic Adenocarcinoma, Stage 0 Pancreatic Cancer American Joint Committee on Cancer v8, Stage I Pancreatic Cancer American Joint Committee on Cancer v8, +2 more
Locations: OHSU Knight Cancer Institute Portland, Oregon, United States

View Trial Details

Active, Not Recruiting

PROACTIVE: Surgical Resection Outcomes in Locally Advanced and Unresectable Pancreatic Cancer After Neoadjuvant Chemotherapy

NCT06132087

Conditions: Locally Advanced Pancreatic Adenocarcinoma, Stage III Pancreatic Cancer American Joint Committee on Cancer v8, Unresectable Pancreatic Adenocarcinoma
Locations: USC / Norris Comprehensive Cancer Center Los Angeles, California, United States

View Trial Details